The following is a guest post by Daniel R. Lucey MD, MPH, FIDSA As of May 20, 2020 more than 93,000 deaths in people laboratory-confirmed to have COVID-19 have been reported in the United States and more than 1.5 million persons have tested positive for SARS-CoV-2. All 50 states have now begun partially reopening. It […]
HIV
Amid unprecedented challenges to routine healthcare access, trial results mark a first for a critically needed HIV prevention measure An investigational drug administered by injection every […]
Tuberculosis
In the six weeks before South Africa responded its first diagnoses of COVID-19 with the start of physical distancing measures, more than 47,000 people on average […]
Research & Development
What we have learned from HIV can guide responses to COVID-19 that are innovative, effective and inclusive, and can help end the pandemic faster The following […]
Policy
The following is a guest post by Kenneth G. Castro, MD, FIDSA Since its formation in 1948, WHO has relied heavily on the U.S. for collaborations […]